109 related articles for article (PubMed ID: 30317880)
21. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model.
Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM
Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199
[TBL] [Abstract][Full Text] [Related]
22. Investigation on cell proliferation with a new antibody against thymidine kinase 1.
Wang N; He Q; Skog S; Eriksson S; Tribukait B
Anal Cell Pathol; 2001; 23(1):11-9. PubMed ID: 11790855
[TBL] [Abstract][Full Text] [Related]
23. Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker.
Jagarlamudi KK; Shaw M
Biomark Med; 2018 Sep; 12(9):1035-1048. PubMed ID: 30039979
[TBL] [Abstract][Full Text] [Related]
24. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
25. Serum thymidine kinase 1 activity in solid tumor (breast and colorectal cancer) patients treated with adjuvant chemotherapy.
Bolayirli M; Papila C; Korkmaz GG; Papila B; Aydoğan F; Karataş A; Uzun H
J Clin Lab Anal; 2013 May; 27(3):220-6. PubMed ID: 23686779
[TBL] [Abstract][Full Text] [Related]
26. Thymidine kinase and cancer monitoring.
Aufderklamm S; Todenhöfer T; Gakis G; Kruck S; Hennenlotter J; Stenzl A; Schwentner C
Cancer Lett; 2012 Mar; 316(1):6-10. PubMed ID: 22068047
[TBL] [Abstract][Full Text] [Related]
27. Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.
Jagarlamudi KK; Hansson LO; Eriksson S
BMC Cancer; 2015 Feb; 15():66. PubMed ID: 25881026
[TBL] [Abstract][Full Text] [Related]
28. A simple quantitative assay for the activity of thymidine kinase 1 in solid tumors.
Brockenbrough JS; Rasey JS; Grierson JR; Wiens LW; Vesselle H
Nucl Med Biol; 2007 Aug; 34(6):619-23. PubMed ID: 17707801
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endothelial cell growth factor, and proliferation markers in colorectal cancer.
van Triest B; Pinedo HM; Blaauwgeers JL; van Diest PJ; Schoenmakers PS; Voorn DA; Smid K; Hoekman K; Hoitsma HF; Peters GJ
Clin Cancer Res; 2000 Mar; 6(3):1063-72. PubMed ID: 10741735
[TBL] [Abstract][Full Text] [Related]
30. Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.
He Q; Mao Y; Wu J; Decker C; Merza M; Wang N; Eriksson S; Castro J; Skog S
Int J Oncol; 2004 Oct; 25(4):945-53. PubMed ID: 15375544
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Expression of CD31 (PECAM-1) in Nonendothelial Tumors of Dogs.
Ramos-Vara JA; Miller MA; Dusold DM
Vet Pathol; 2018 May; 55(3):402-408. PubMed ID: 29343200
[TBL] [Abstract][Full Text] [Related]
32. 5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts.
Wang L; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):858-62. PubMed ID: 18600552
[TBL] [Abstract][Full Text] [Related]
33. Correlation of 4'-[methyl-
Takami Y; Yamamoto Y; Ueno M; Chiba Y; Norikane T; Hatakeyama T; Miyake K; Toyohara J; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):634-641. PubMed ID: 30039191
[TBL] [Abstract][Full Text] [Related]
34. Enzymatic regulation of cytosolic thymidine kinase 1 and mitochondrial thymidine kinase 2: a mini review.
Munch-Petersen B
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):363-9. PubMed ID: 20544521
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level.
Kataoka Y; Iimori M; Niimi S; Tsukihara H; Wakasa T; Saeki H; Oki E; Maehara Y; Kitao H
Sci Rep; 2019 May; 9(1):7964. PubMed ID: 31138881
[TBL] [Abstract][Full Text] [Related]
36. A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management.
Jagarlamudi KK; Moreau L; Westberg S; Rönnberg H; Eriksson S
PLoS One; 2015; 10(9):e0137871. PubMed ID: 26366881
[TBL] [Abstract][Full Text] [Related]
37. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.
Kiss DL; Waters CE; Ouda IM; Saldivar JC; Karras JR; Amin ZA; Mahrous S; Druck T; Bundschuh RA; Schoenberg DR; Huebner K
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):374-382. PubMed ID: 28093273
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
39. Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management.
Guan H; Sun Y; Zan Q; Xu M; Li Y; Zhou J; He E; Eriksson S; Wen W; Skog S
Mol Med Rep; 2009; 2(6):923-9. PubMed ID: 21475922
[TBL] [Abstract][Full Text] [Related]
40. Thymidine kinase in epithelial ovarian cancer: relationship with the other pyrimidine pathway enzymes.
Fujiwaki R; Hata K; Nakayama K; Moriyama M; Iwanari O; Katabuchi H; Okamura H; Sakai E; Miyazaki K
Int J Cancer; 2002 May; 99(3):328-35. PubMed ID: 11992400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
